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a b s t r a c t
Adenovirus type 2 RNA splicing events were quantitatively mapped by using deep cDNA sequencing. The
majority of the previously identiﬁed splice sites were detected. The lack of complete consistency
between the present and previous results is because of some sites which were incorrectly mapped in
previous studies, such as the splice sites for pVII, pVIII and E3-11.6K. Several previously predicted splice
sites such as that for E3-14.5K and E4ORF3/4 were not detected. In addition, several new splice sites
were identiﬁed. The novel RNAs may code for hitherto undetected proteins or alternatively spliced
mRNAs for known proteins. The open reading frames downstream of two novel splice sites, located in
the major late transcription unit region, were shown to be highly conserved. Another interesting
possibility is that some of them are non-coding RNAs. Finally, the adenovirus mRNA polyadenylation
sites were accurately mapped and in some cases shown to be heterogeneous.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Adenoviruses are non-enveloped, icosahedral viruses contain-
ing a linear, double-stranded DNA molecule (Green et al., 1967).
Both strands are transcribed with genes located on both the so-
called rightward reading strand (r-strand) and leftward reading
strand (l-strand). The genome consists of ﬁve early transcription
units (E1A, E1B, E2, E3 and E4), two intermediate units (IX and
IVa2) and one major late unit that generates ﬁve families of late
mRNAs (for review (Shenk, 1996)). An additional late l-strand
transcription unit encoding the U exon protein (UXP) has been
identiﬁed recently (Tollefson et al., 2007; Ying et al., 2010). Each
transcription unit contains its own promoter, and most of them
encode more than two mRNAs by differential splicing of a single
linear transcript. Expression of adenovirus genes is regulated
during the productive infection in a step-wise manner. The
immediate early gene E1a is expressed ﬁrst followed by the
expression of the delayed early genes, E1B, E2, E3 and E4. Then
the intermediate early genes, IVa2 and IX are expressed. L1, a late
transcript from the major late promoter, is also made during this
phase. Soon after the onset of viral DNA synthesis, the transcrip-
tion is switched from an early to a late mode for the production of
viral structural proteins. Adenovirus makes an extensive use
of alternative RNA splicing to produce a very complex set of
mRNAs. Except for the polypeptide IX mRNA, all adenovirus
primary transcripts undergo one or more splicing events which
give rise to about ﬁfty distinct mRNAs during a lytic infection.
From early region E1A, three major mRNAs, the 13S, 12S and 9S
mRNAs, and two minor mRNAs, the 10S and 11S mRNAs, are
produced by alternative splicing (Berk and Sharp, 1978; Chow et
al., 1979; Perricaudet et al., 1979; Schmitt et al., 1987; Spector et al.,
1978; Virtanen and Pettersson, 1983). These mRNAs have common
50 and 30 ends, but differ from each other by the size of the intron.
The E1A 13S and 12S mRNAs are the most abundant RNA species
early after infection, while the 9S mRNA represents less than 5% of
the total E1A mRNAs. At late times, a shift in the steady-state
levels of the mRNAs occurs and the 9S mRNA becomes the most
abundant species. Transcription of region E1B generates two major
mRNAs (22S and 13S) and two minor mRNAs (14.5S and 14S) by
splicing of one or two introns from a common precursor RNA (Berk
and Sharp, 1978; Spector et al., 1978; Virtanen and Pettersson,
1983). The 22S and 13S mRNAs are the predominant species
whereas the 14.5S and 14S mRNA represent less than 5% of the
total steady-state level of E1B mRNAs (Babich and Nevins, 1981).
Following the progression of the infection, the abundances of E1B
22S and 13S mRNAs are changed from equal amounts during the
early stage to approximately 20-fold excess of 13S mRNA at late
times. Region E2 is transcribed from the l-strand by using alter-
native promoter sites for the initiation of transcription. Two major
classes of transcripts, E2A and E2B, have been described (Chow et
al., 1979; Stillman et al., 1981). Although multiple mRNAs are
produced from E2A, one mRNA encoding a single-stranded DNA-
binding protein (DBP) is dominant. It is produced by the removal
of two introns from the pre-mRNA. E2B precursor RNAs bypass the
polyadenylation signal used for E2A mRNAs and extend to a
downstream polyadenylation site. Two major proteins, the 87K
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terminal protein (pTP) and the 140K DNA polymerase (Adv-Pol),
are translated from the E2B mRNAs. They are both involved in
adenovirus DNA replication (Smart and Stillman, 1982; Stillman et
al., 1981, 1982). During the late stages of infection UXP is
expressed abundantly from the l-strand from its own promoter,
but its function remains unknown (Tollefson et al., 2007; Ying et
al., 2010). The E3 transcription unit is embedded within the major
late transcription unit and several of the splice sites are utilized in
the maturation of the ﬁber mRNA. Previous studies have identiﬁed
at least nine E3 mRNAs which are generated by differential
processing of two major RNA precursors, E3A and E3B. The
precursors share a common cap site, but differ from each other
by having different 30-ends. The E3B has one poly(A) addition site
at 30846, whereas E3A has four poly(A) addition sites at 29792,
29799, 29801 and 29804. The E3 mRNAs are translated into seven
proteins, namely 12.5K, 6.7K, gp19K, 11.6K, 10.4K, 14.5K and 14.7K
(Wold et al., 1995). These proteins play a very important role in
counteracting the antiviral defenses of the host (Gooding, 1992;
Gooding and Wold, 1990). The E4 transcription unit is located at the
right end of the l-strand (Pettersson et al., 1976; Sharp et al., 1974). A
single primary transcript is spliced and generates a very complicated
set of mRNAs and as many as 24 mRNAs with identical 50 and 30
ends have been reported (Freyer et al., 1984; Herisse et al., 1981;
Rigolet and Galibert, 1984; Tigges and Raskas, 1984; Virtanen et al.,
1984). E4 contains seven open reading frames (ORFs), and all except
ORF3/4 polypeptides have been detected in infected cells.
Nearly all of transcription from the major late transcription unit
(MLTU) starts at the onset of adenovirus DNA replication. Primary
transcripts are generated from a single promoter and they are
polyadenylated at one of ﬁve different sites, generating ﬁve
families of RNAs, L1–L5. A minimum of 20 mRNAs are generated
from the MLTU, and nearly all of them have a common 201-
nucleotide tripartite leader sequence at their 50 ends. Some of
them contain an additional 440-nucleotide long i-leader exon. The
L1 pre-mRNA is transcribed both at intermediate and late times,
but its splicing pattern changes with time. The mRNA which codes
for the two structurally related polypeptides 52K and 55K is
produced both at intermediate and late times after infection,
whereas the IIIa mRNA is produced exclusively in the late phase.
Two poly(A) addition sites at 14113 (the most abundant) and 14119
were identiﬁed (Hales et al., 1988; Prescott and Falck-Pedersen,
1994).The L4-100K and L4-22K mRNAs are transcribed at a
relatively early time of the late phase (Larsson et al., 1992). The
L4-22K mRNA is transcribed from an internal L4 promoter
embedded in the ORF of L4-100K (Morris et al., 2010). The L4-
22K protein suppresses adenovirus early gene expression, but
activates the full panel of L1-L5 transcription. The L4-33K protein
is virus-encoded alternative RNA splicing factor and has been
shown to activate splicing of Ad late gene transcripts with weak 30
splice sites (Tormanen et al., 2006). Furthermore, L4-33K protein
regulates selective accumulation of Ad late gene transcripts (Wu et
al., 2013). All remaining late mRNAs are produced in the late
phase. The L2 pre-mRNA is spliced into four major mRNAs with a
common poly(A) addition site at nt 17969 and encoding polypep-
tides pIII (penton base), pV (major core protein), pVII (core
protein) and pX (pμ) (Akusjarvi and Persson, 1981; Le Moullec et
al., 1983); the L3 pre-mRNA is spliced into three major mRNAs
with a common poly(A) site at nt 22443 which encode polypep-
tides pVI (hexon associated protein), pII (hexon) and the 23K viral
protease (Prescott and Falck-Pedersen, 1994); the L4 pre-mRNA is
spliced into four polypeptides, 100K, 22K, 33K and pVIII (hexon
associated protein) with a common poly(A) site at nts 28223 and
28228 (Sittler et al., 1994); and ﬁnally, L5 includes transcripts
encoding only pIV (ﬁber) with a poly(A) addition site at nt 32798.
L5 mRNAs comprise a family of transcripts with a number of
different 50-leader sequences (x, y, z leaders) in various
combinations in addition to leaders 1, 2, 3 and i (Le Moullec et
al., 1983; Uhlen et al., 1982).
For decades, adenoviruses have served as an outstanding model
system to study the molecular mechanisms of splicing due to the
simplicity of their genomes and their efﬁcient mode of replication.
Most adenovirus mRNAs are generated by the removal of one or
more introns and most of these introns are located in the 50 or 30
noncoding portion of pre-mRNA. Thus the viral introns do only in
a few cases interrupt the ORFs. The development of high through-
put sequencing methods has facilitated the discovery of many
novel transcribed regions and splicing isoforms (Djebali et al.,
2012). It is also a very powerful tool to study alternative splicing
under different conditions at an unprecedented depth. Here we
present a comprehensive analysis of adenovirus RNA splicing
during different phases of the infection and a complete adenovirus
splicing map. Two deep sequencing experiments, single-end and
paired-end sequencing, were performed. Single-end sequencing
was done by using the standard single-read DNA library prepara-
tion. The major shortcoming of this procedure is the short
sequence reads and an exponential increase in error rates along
the reads (Cox et al., 2010). The more recently developed paired-
end sequencing allows for reading 255 nt long sequences from
both ends of cDNA fragments. The data generated from paired-end
sequencing, utilized in our second experiment, should thus be
more reliable.
Results and discussion
Summary of sequencing results
Using mRNA single-end and total RNA paired-end sequencing
technologies, the Ad2 RNA splicing proﬁle during different phases
was studied. Infection and RNA isolation were performed as in our
previous study (Zhao et al., 2007). Brieﬂy, synchronized human
primary lung ﬁbroblasts (IMR-90) were infected at a multiplicity
of 100 FFU/cell. Infected cells were collected at 6, 12, 24, and
36 hpi. As shown in our previous study, these time points
represent different stages of the infectious cycle, i.e. before any
adenoviral gene expression, after immediate early gene (E1a)
expression, after the onset of adenoviral DNA replication, and
after late gene expression, respectively (Zhao et al., 2007). Thus,
we could correlate the expression of RNAs with the progression of
the infection. Single- and paired-end sequencing was performed.
Only three RNA samples from 12 hpi, 24 hpi and mock were
subjected to single-end sequencing in a pilot experiment whereas
all RNA samples including 6 hpi, 12 hpi, 24 hpi, 36 hpi and mock
were sequenced by paired-end sequencing. Single-end sequencing
yielded 50–54 million 76 bp long sequence reads per sample, as
shown in our previous publication (Zhao et al., 2012). The fraction
of reads that aligned to the adenovirus genome increased drama-
tically, from 1.3 million reads at 12 hpi to 15.9 million reads at
24 hpi, indicating a very efﬁcient infection (Table 1). The 401 reads
that were aligned to the adenovirus genome in the mock sample
represented the background noise. In the case of paired-end
sequencing 30 million of 255 bp long sequence reads per sample
were generated. The sequence reads that mapped to the adeno-
virus genome increased dramatically after 12 hpi. By using TopHat
(Trapnell et al., 2009), an efﬁcient read-mapping algorithm
designed to align the sequence reads to reference genome without
relying on known splice sites, 2228 and 1460 adenovirus splice
junctions (with more than 1 sequence reads) were identiﬁed
by single-end and paired-end sequencing, respectively. Although
more splice junctions were identiﬁed by single-end sequencing,
their sequence coverage was much lower than seen with
paired-end sequencing. In general, the number of sequence reads
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covering splice junction generated by paired-end sequencing was
10 times higher than generated by single-end sequencing. Thus
suggesting that the speciﬁcity of the paired-end sequencing data
was higher than obtained with single-end sequencing. Considering
the difference in accuracy and sensitivity between the two data
sets, different criteria were used for scoring new splice junctions.
The splice junctions, covered by more than 100 sequence reads
from single-end sequencing or more than 1000 reads from paired-
end sequencing, were considered as signiﬁcant. However, most of
the result presented here are based on pair-end sequencing data.
At 6 hpi, no or very low adenovirus gene expression was detected
in IMR-90 cell as shown in our previous study (Zhao et al., 2007).
Correspondingly, very few viral splice junctions were detected.
Most splice junctions with signiﬁcant sequence recovery were
detected after 12 hpi and increased rapidly from 12 to 24 hpi,
which correlated with the progression of the infection. The
complete list of splice junctions aligned to adenovirus genome
has been submitted to the National Center for Biotechnology
Information Gene Expression Omnibus (http://www.ncbi.nlm.nih.
gov/geo) under accession no. GSE54583.
Changes of adenovirus RNA splicing proﬁle during the progression of
the infection
To reveal the changes in the adenovirus splicing proﬁle the
relative abundance of each splice junction, measured by paired-
end sequencing, was calculated at each time point. Splice junctions
representing more than 1% of all viral splice junctions at any given
time point were considered as the most signiﬁcant and included in
Tables 2A–2C. The sequence reads that aligned to the adenovirus
genome at 6 hpi were very low (see in Table 1), and were not
included in this analysis. At 12 hpi, the most signiﬁcant splice
junctions were located on the l-strand (highlighted in bold text in
Table 2A) whereas only two splice junctions were on the r-strand,
in region E3. The splice junctions located within the E4 region
were the most signiﬁcant and the splice junction for E4ORF3
accounted for 53.8% of all adenovirus splice junctions at this time.
The splice junctions situated in the E2 region were also prominent.
Their relative abundance decreased rapidly with time and they
accounted for 9.7% and 2.3% of all adenovirus splice junctions at 24
and 36 hpi, respectively. The splice junction for E4ORF3 fell to
0.66% at 24 hpi. The splice junctions within regions E1A and E1B
were also detected, but they contributed to less than 1% of all viral
splice junctions (see next section).
Following the progression of the infectious cycle into the S
phase at 24 hpi, adenovirus late gene expression started. Conse-
quently, a large number of splice junctions located within the
major late transcription unit (MLTU) were detected. As shown in
Table 2B (bold text), the most abundant splice junctions were
situated within the leader region. The splice junctions for adeno-
virus late proteins, such as 55/52K, 13.6K, 33K and 100K, became
prominent. It is noteworthy that L4 splices appeared earlier than
splices in regions L2, L3, and L5. The explanation is presumably
that L4 contains a promoter that is embedded in the coding
sequence for the 100K protein. Although the percentage of splice
junctions within the E2 and E3 regions was decreasing at 24 hpi
and there was a noteworthy increase in their abundance. The
splice junction for the recently discovered U gene on the l-strand
(UXP) reached its highest expression at this time point.
In the late phase, the rate of transcription from the MLP increased
to a level about 20 times higher than that from the early transcrip-
tion units (Shaw and Ziff, 1980). All splice junctions which
Table 1
Summary of sequencing data.
Technique Detection Total Mock Ad-6 hpi Ad2-12 hpi Ad2-24 hpi Ad2-36 hpi
Single-end seq Total reads 53,146,621 50,045,456 54,355,211
Aligned to human
31,696,007 (59.6%)a 29,549,346 (59%) 35,346,824 (33.9%)
Aligned to Ad2 genome 401 (0.0%)b 1,358,215 (2.7%) 15,922,575 (29.3.0%)
Splice junction 2228 2 102 2,191
(Z1 reads)
Splice junction 251 0 23 238
(Z100 reads)
Splice junction 45 0 9 44
(Z1000 reads)
Paired-end seq Total reads 32,017,993 34,571,161 35,084,650 29,991,204 34,995,648
Aligned to human
22,906,437 23,590,900 17,354,900 15,276,823 6,750,352
71.5% 68.2% 49.5% 50.9% 19.3%
Aligned to Ad2 genome 7428c 71,269 354,140 6,339,287 20,352,847
(0.03%) (0.2%) (1.0%) (21.1%) (58.2%)
Splice junction 1460 43 55 99 551 1064
(Z1 reads)
Splice junction 545 2 3 26 223 467
(Z100 reads)
Splice junction 178 0 0 7 78 145
(Z1000 reads)
a Percentage of sequence reads that aligned to the human genome.
b Percentage of sequence reads that aligned to the adenovirus genome.
c The sequence reads in the sample from mock infected cells that aligned to the adenovirus genome are largely due to a minimal accidental contamination of RNA with
the 36 hpi sample.
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constituted 41% of all viral splice sites at 36 hpi were located
within the MLTU as shown in Table 2C. The splice junctions between
leaders 1, 2 and 3 were still highest and accounted for more than
64% of all sequence reads covering adenovirus splice junctions. All
remaining splice junctions which accounted for more than 1% of all
viral splice junctions were located in L1–L5 regions.
Splice junctions within the E1A and E1B transcription units
E1A is an immediate early gene which is expressed ﬁrst but at a
very low level. Previous studies have shown that ﬁve mRNAs are
produced from E1A region, three major products, 13S, 12S and 9S
mRNAs, and two minor products, the 10S and 11S mRNAs (Schmitt
et al., 1987). Here, we detected 4 splice junctions which matched
exactly those identiﬁed in the earlier studies (Fig. 1). The sequence
reads covering splice junctions for the 10S and 11S mRNAs were
very low. Another consistency with earlier studies was the kinetics
of E1A splicing. The 12S and 13S mRNAs were most abundant at 12
and 24 hpi, whereas 9S mRNA became the most abundant later
(Schmitt et al., 1987). The relative abundance of 12S and 13S was
different at different stages of infection. The 13S was more
abundant at 12 hpi unlike at 24 hpi. These results consistent with
Table 2A
The most signiﬁcant splice junctions detected at 12 hpi (representing 41% of all viral splice junctions at this time point) and their abundances at late times.
Splice junction Sequence reads by paired-end seq Intron length mRNA
Start End Strand Mock Ad-6 hpi Ad-12 hpi Ad-24 hpi Ad-36 hpi
35547 34736  18 177 19628 (53.8%)a 6043 (0.66)% 681 (0.02%) 812 E4orf3
27981 28375 þ 34 22 4605 (12.6%) 28,374 (3%) 43,507 (1.4%) 395 E3
27024 24792  3 16 2135 (5.9%) 17,052 (1.8%) 4201 (0.1%) 2233 E2A/E2B
24714 24089  0 11 1652 (4.5%) 24,348 (2.6%) 10,003 (0.3%) 626 E2A
35547 34436  0 2 1124 (3.1%) 346 (0.04%) 37 1112 E4 region
35547 34330  2 1 1059 (2.9%) 421 (0.05%) 68 1218 E4 region
24714 24378  1 1 746 (2%) 3888 (0,4%) 1450 (0.05%) 337 E2 region
24196 24089  0 0 575 (2%) 1896 (0.2%) 387 (0.01%) 108 E2 region
24193 24089  0 0 498 (1.4%) 1981 (0.2%) 372 (0.01%) 105 E2 region
28560 30437 þ 4 21 429 (1.2%) 6375 (0.7%) 12392 (0.4%) 1878 E3
a Percentage of sequence reads covering a given splice junction relative to the total sequence reads covering all adenovirus splice junctions. For clarity the data at 12 hpi
is highlighted in red.
Table 2B
The most signiﬁcant splice junctions detected at 24 hpi (representing 41% of all viral splice junctions at this time point) and their abundances at early and late times.
Splice junction Sequence reads by paired-end seq Intron length mRNA
Start End Strand Mock Ad-6 hpi Ad-12 hpi Ad-24 hpi Ad-36 hpi
7173 9633 þ 486 425 343 (0.9%) 281,568 (30.5%)a 1,426,350 (44.8%) 2461 Leaders 2–3
6080 7100 þ 352 223 187 (0.5%) 166,717 (18.1%) 573,713 (18%) 1021 Leaders 1–2
9724 11039 þ 41 33 96 (0.26%) 48,483 (5.3%) 75,495 (2.4%) 1316 Protein 52, 55K
7173 7941 þ 64 29 40 (0.1%) 32,416 (3.5%) 45,039 (1.4%) 769 Leaders 2–i
8382 9633 þ 24 15 28 32,309 (3.5%) 54,467 (1.7%) 1252 Leaders i–3/13.6K protein
26552 26753 þ 9 0 15 31,039 (3.4%) 88,362 (2.8%) 202 33k Protein
27981 28375 þ 34 22 4605 (12.6%) 28,374 (3.1%) 43,507 (1.4%) 395 Leaders X–Y/E3
9724 24094 þ 31 24 12 27,968 (3%) 61,766 (1.9%) 14371 100K
24714 24089 - 0 11 1652 (4.5%) 24,348 (2.6%) 10,003 (0.3%) 626 E2A
24792 27024 - 3 16 2135 (5.9%) 17,052 (1.9%) 4201 (0.1%) 2233 E2A/E2B
9724 16515 þ 32 32 18 16,289 (1.8%) 89,029 (2.8%) 6792 Core protein V
30855 24792 - 0 0 24 9348 (1%) 5599 (0.2%) 6064 UXP
a As described in Table 2A.
Table 2C
The most signiﬁcant splice junctions detected at 36 hpi (representing 41% of all viral splice junctions) and their abundances at early times.
Splice junction Paired-end seq Intron length mRNA
Start End Strand Mock Ad-6 hpi Ad-12 hpi Ad-24 hpi Ad-36 hpi
7173 9633 þ 486 425 343 (0.9%) 281,568 (30.1%) 1,426,350 (44.8%)a 2461 Leaders 2–3
6080 7100 þ 352 223 187 (0.5%) 166,717 (18.1%) 573,713 (18%) 1021 Leaders 1–2
9724 16515 þ 32 32 18 16,289 (1.8%) 89,029 (2.8%) 6792 Core protein V
26552 26753 þ 9 0 15 31,039 (3.4%) 88,362 (2.8%) 202 33k Protein
9724 11039 þ 41 33 96 (0.3%) 48,483 (5.3%) 75,495 (2.4%) 1316 52, 55K
9724 28375 þ 35 17 7 6978 (0.8%) 74,604 (2.3%) 18652 Leaders 3–Y
9724 24094 þ 31 24 12 27,968 (3%) 61,766 (1.9%) 14371 100K
8382 9633 þ 24 15 28 32,309 (3.5%) 54,467 (1.7%) 1252 13.6K Protein
7173 7941 þ 64 29 40 (0.1%) 32,416 (3.5%) 45,039 (1.4%) 769 Leaders 2–i
27981 28375 þ 34 22 4605 (12.6%) 28,374 (3.1%) 43,507 (1.4%) 395 Leaders X–Y
9724 18801 þ 13 14 11 5418 (0.6%) 39,521 (1.2%) 9078 Hexon
28560 31029 þ 16 15 11 5447 (0.6%) 36,841 (1.2%) 2470 Leader Y–ﬁber
a As described in Table 2A.
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the kinetics of 12S and 13S mRNA transcription in a previous study
(Svensson et al., 1983). The inefﬁcient splicing of 10S and 11S
mRNA is most likely due to the unusually long distance between
the branch point sequence and the 30 splice site in the ﬁrst intron
(Chebli et al., 1989; Gattoni et al., 1988).
From E1B, a single primary transcript is produced which gives
rise to two major mRNAs, 13S and 22S, and two minor mRNAs, the
14.5S and 14S mRNAs, by 4 alternative splicing events. Splicing in
E1B peaked later than splicing in E1A starting at 24 hpi. Splicing of
E1B RNAs was regulated over time. At 24 hpi, splicing occurred
predominantly at 2250–3588 and accounted for 80% of all splicing
within E1B region. It then decreased to 70% at 36 hpi, when
splicing between 3505–3588 and 2250–3211 was increased. The
splicing between 2250 and 3269 remained at similar level. In
addition to the four previously described splice sites, a new splice
site from 2250 to 3591 was detected. Its intron is three nucleotides
longer at the 30-end than that of the 13S mRNA. The resulting
mRNA would encode a protein which is one amino acid shorter
than that encoded by 13S mRNA. However, this splice junction was
7–8 fold less abundant than that of the authentic 13S mRNA,
suggesting that it played a less signiﬁcant functional role.
Splicing in the E3 transcription unit
The E3 region is located entirely within the MLTU (Wold et al.,
1995). At least nine mRNAs have been reported from this region by
alternative splicing of two major RNA precursors, E3A and E3B.
Two splice sites coincide with the splice sites for the leaders X, Y
and Z which are present on ﬁber mRNAs. Here, seven splice
junctions were identiﬁed, four of which (A, E, G and H as shown
in Fig. 2) were identical with previously described sites. Three 30
splice sites were new (the second intron of B–D). The 30splice site
of the 2nd intron for gp19K was 28742 instead of 28772 (B). Two
alternative splice sites, 29347 (C) and 29398 (D) seem to be used
for the E3 11.6K (CR1-β) mRNA instead of 29465 which was
undetectable. One previously reported splice site (F) for the
14.5K (RID-β) mRNA, 28560–30058, was also undetectable. The
coverage of the two splice sites C and D for 11.6K (CR1-β) was
similar at 24 hpi, although the site between 28560 and 29347
(C) was preferentially used at 36 hpi. A rare 50 splice site (H) for
14.7K was identiﬁed, but the sequence reads were 9-fold lower
than from the major site (G) and detectable only at 36 hpi. No
speciﬁc mRNA for the RID-β protein was detected in the present
study. It seems likely that the mRNA with a splice between 28560
and 29764 is polycistronic and encodes both the RID-alpha and
-beta proteins (Tollefson et al., 1990a, 1990b). Most splicing in the
E3 region occurred during the early phase of the infection (12 hpi)
and continued until late (36 hpi).
Splicing in the E4 transcription unit
The E4 transcription unit is located at the extreme right end of
the l-strand of the genome (Berk and Sharp, 1978; Chow et al.,
1979; Kitchingman and Westphal, 1980; Pettersson et al., 1976).
Fig. 1. A splicing map of the E1A and E1B transcription units. The green arrows represent the known E1A and E1B transcripts. The red arrow is a predicted transcript. The red
lines indicate the known splice sites. The green line is a new splice site. The blue open boxes are ORFs. The numbers indicate the positions of ORFs and the splice junctions on
the Ad2 genome. The red open boxes and numbers are predicted ORFs and their positions. For reference, the E1 region is shown at the bottom of ﬁgure with marked
nucleotide positions. The sequence reads covering the splice sites are listed in the table at the bottom.
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Previous studies have shown that the primary transcript from the
E4 region is spliced into a complicated set of mRNAs. At least 24
mRNAs have been detected by sequence analysis of cDNA clones
and S1 nuclease analysis (Freyer et al., 1984; Herisse et al., 1981;
Rigolet and Galibert, 1984; Tigges and Raskas, 1984; Virtanen et al.,
1984). These mRNAs have common 50 and 30 ends but differ in
their internal splicing patterns. Our sequencing results identiﬁed
only ten splice junctions. The sequence reads for most of them
were very low. The splice junctions for ORF2, ORF3, ORF4, ORF6
and ORF6/7 (B–D, F and G as shown in Fig. 3), as well as the splice
junctions of 33903–33284, 34288–34083 and 34605–34436 were
consistent with those previously reported. No sequence reads
covering the splice junction (E) in the mRNA for the ORF3/4
protein was detected. Two new splice sites from 35547 to 34330
or 343242 (H) were identiﬁed. The sequence reads covering the
splice site 35547–34330 was the third most abundant in the E4
region at 12 hpi. Although the sequence reads which covered the
junction 35547–343242 were very low; they were comparable
with those covering other well deﬁned splice sites, such as that in
the mRNA for the E4ORF2 protein. In addition, this splice junction
was identiﬁed by both single- and paired-end sequencing. How-
ever, the predicted ORF downstream of the splice junction, 35547–
34330 which starts at 34291 and ends at 34229 is only 63 nt long.
Its biological function is thus uncertain. The predicted ORF which
followed the splice junction 35547–34242 was from 34229 to
34211 and is thus unlikely to encode a protein. However, there
follows an additional ORF located between 34077 and 33193 for
ORF6. As mentioned early (shown in Table 2A), splicing in the E4
region was the most signiﬁcant at 12 hpi and constituted about
60% of all adenovirus RNA splicing. Furthermore, the splicing of
RNAs in E4 region was under a temporal control. Splicing of ORF2,
ORF3, ORF4 and one of the new site 35547–34330 reached their
maximums at 12 hpi, whereas ORF6, ORF6/7, as well as the site
33284–33903 and 35547–34242 reached their highest level at
24 hpi. Temporal regulation of the spicing pattern has been shown
in previous studies (Dix and Leppard, 1993; Ross and Ziff, 1992;
Tigges and Raskas, 1984). Based on their expression pattern, E4
mRNAs are divided into two classes: mRNAs of early classes
included ORF2, ORF3, ORF4 and ORF6 synthesized during the early
phase of infection; mRNAs of the later class included ORF1 and
ORF6/7 and are synthesized later. Our result suggested that the
synthesis of ORF6 and ORF6/7 mRNA started from the early phase
at a low level, but their most efﬁcient production occurred at the
late phase.
Splicing of RNA from the E2 transcription unit
The splice junctions in the E2 region form a complicated
pattern. All previously identiﬁed splice sites were detected in both
data sets (Fig. 4). The splice junction for E2A (at nts 24714–24089)
and the common splice junction for E2A and E2B (24792–27024)
had the highest coverage. The sequence reads covering the splice
junctions in the UXP mRNA (30855–24792) and in the mRNA that
is transcribed from the late E2 promoter (25885–24792) E2A-L
were also very high. They reached their peak at 24 hpi, and then
decreased. The coverage of the splice junction that is unique for
E2B was low. In particular, the sequence reads representing the pol
mRNA were very low in both data sets. Many new splice junctions
were identiﬁed within the E2 region, most of them being located
within the large splice site between 24714 and 14293. However,
Fig. 2. A splicing map of the E3 transcription unit. The green and red arrows represent the E3A and E3B mRNAs, respectively. The thickness of the arrow indicates the relative
abundance of the sequence reads covering the splice junction. The thin lines indicate the splice sites. The thin green lines are a new splice sites identiﬁed here. The gray lines
are the undetectable splice sites. The black and red numbers indicate the positions of the splice sites and ORFs on the Ad2 genome, respectively. For reference, a part of the
Ad2 DNA is shown at the bottom of ﬁgure with marked nucleotide positions. The sequence reads covering the splice sites are listed in the table at the bottom.
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most of them could only be detected by paired-end sequencing.
Only four novel splice junctions, 20867-20739, 24193-24089,
24196-24089 and 24714-24378, could be detected in both data
sets. Splicing at these sites occurred mostly during the early phase
starting at 12 hpi and reaching the highest level at 24 hpi. The new
splice junctions at 24193/24196-24089 and 24714-24378 might be
alternative splices for E2A since the latter shares its splice donor
site and the former shares its splice acceptor site with the major
E2A mRNA. The sequence reads covering these two new splice
junctions were, however, about six time lower than those covering
the major E2A splice site (24714-24089), suggesting that they play
a less signiﬁcant role if they indeed are alternative splice sites for
E2A. The sequence reads covering the splice junction 20867-20739
were high as compared with those for pTP and Ad-pol (14105-
8775, 14105-10580 and 24714-14293).The E2B mRNAs share their
poly(A) site with the IVa2 mRNA which is expressed during the
intermediate phase of the infection. The previously described
splice site (5695-5418) in the latter mRNA was conﬁrmed by both
single- and paired-end sequencing.
Splices in the major late transcription unit
The majority of the splice junctions at 24 and 36 hpi were
located on the r-strand, and furthermore, about 80% of them were
located within the MLTU. The sequence reads that covered the
splice junctions within the tripartite leader region were most
abundant after 24 hpi. Splicing occurred predominately between
leaders 1 and 2 as well as leaders 2 and 3, and these splice
junctions account for approximately 80% and 90% of all the
detected splice junctions within the tripartite leader region at 24
and 36 hpi, respectively. However, a variety of alternative splice
junctions were also detected within the leader region, especially in
the data set obtained by paired-end sequencing and the most
common splice junctions detected in both sequencing experi-
ments are shown in Fig. 5. The splices between leaders 2 and i
and between leaders i and 3 account for 11.6% and 4.5% at 24 and
36 hpi, respectively. Nearly all the remaining splice junctions
contributed each to less than 1% of all splice junctions in this
region, except the one between nts 9113 and 9197 which reached
1.2% at 24 hpi. It differs from most of the other aberrant splices in
the leader region by not employing any of the known 50 or 30splice
sites, involved in splicing of the tripartite leader. The low abun-
dance of these splice sites makes it unlikely that these splice sites
play important functions.
A large set of splice junctions had a common 50 junction at
9724 as shown in Table 3. They coincided with the known splice
sites for the capsid proteins except for pVII and pVIII. Previously
identiﬁed 30-splice sites at 15853 and 27194 for these polypep-
tides were not detected (Alestrom et al., 1984; Sung et al., 1983).
Instead, we identiﬁed three new candidate 30 splice sites at
15653, 15659, and 15723 for pVII and one site at 27030 for pVIII.
The ﬁrst downstream ATGs in the corresponding mRNAs were
15873 and 27215 for pVII and pVIII, respectively, suggesting that
they are likely to be the correct splice sites for pVII and pVIII. To
Fig. 3. A splicing map of the E4 transcription unit. The red arrows represent the E4 mRNAs. The thickness of the arrow indicates the relative abundance of the sequence reads
covering the splice junction. The thin lines indicate the position of splice sites. The open boxes are ORFs. The black and red numbers indicate the positions of splice sites and
ORFs, respectively. The dashed boxes are predicted ORFs for the new splice junction. The gray arrow, lines and box indicate an mRNA which was undetectable in the present
study. The sequence reads covering the splice sites are listed in the table at the bottom.
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conﬁrm these results, two PCR experiments were performed to
analyze the new splice sites of pVII. Three primers were designed,
two forward primers, F1- and F2-primer, and one reverse primer,
R-primer. F1 primer covered the splice junction at 9724–15723,
while F2-primer and R-primer located upstream and down-
stream splice of all three splice sites. As shown in Fig. 6, only
one PCR product was produced when F1- and R-primers were
used. The size of the band appeared to be close to 200 nt long,
while the expected PCR product should be 193 nt. Two major
bands were detected when F2-and R-primers were used. The
upper band most likely represented two PCR products of 282 and
288 nt long fragment generated from mRNA with the splice
junction at 9724–15653 and 9724–15659, respectively. The lower
band was the PCR product of 212 nt long produced from mRNA
with splice junction at 9724–15723.
Although the reported splice junction at 9724–26237 for p33K/
22K was detected, it was not the dominant one. A new splice
junction at 9724–26204 was identiﬁed which preceded the same
ORF as 9724–26237. The sequence reads covering this junction
were more than 3-fold higher. Many hitherto undetected splice
junctions were identiﬁed which used 9724 as the splice donor site.
Only those detected by both single-end sequencing and paired-
end sequence analysis were considered and included in Table 3.
The ORF prediction analysis showed that the downstream ORFs
which followed the four 30splice splice sites at 10433, 15029,
15056, and 26753 were less than 200 nt long, making it unlikely
that the corresponding mRNAs encoded proteins. The ORFs
following splice sites, 9724–14455 and 9724–17367, were of
reasonable length, although the sequence reads covering them
were low. Conservation analysis showed the downstream ORFs of
splice sites 9724–14455 and 9724–10433 were highly conserved
among adenoviruses belonging to different subgroups (see
Supplementary material).
The ﬁber gene is the most distal gene in the MLTU. Previous
studies have shown that the 50end of ﬁber mRNA can be spliced
in several different ways, resulting in 5 major species, each
representing 5–70% of the total ﬁber mRNA (Chow and Broker,
1978; Uhlen et al., 1982). Since we could not assemble the full
length mRNA, it was impossible to score all leader arrangements
unambiguously. There are many combinations of putative splices
as shown in Fig. 7. The sequence reads covering the splice
junction between 28560 (30-end Y leader) and 31029 were most
abundant at 36 hpi, accounting for about 50% of all splice
junctions between any leader and the ﬁber mRNA body. The
highly abundant sequence reads covering the splice junction
between leader 3 and leader Y indicate that the ﬁber mRNA with
tripartite leader plus Y leader is the most abundant species late
after infection.
Mapping polyadenylation sites
Our data also allowed us to accurately map poly(A) sites on the
Ad2 genome. Furthermore, our time course experiment enabled us
to quantitatively study the changes of polyadenylation following
Fig. 4. A splicing map for the E2 transcription unit. The red arrows represent the known mRNAs. The green arrows are mRNAs predicted from new splice sites. The thin lines
indicate the positions of splice sites on the Ad2 genome. The black and red numbers indicate the positions of splice sites and ORFs on the Ad2 genome, respectively. The red
lines are newly identiﬁed splice sites. The green dashed boxes and numbers are predicted ORFs and their positions. The sequence reads covering the splice sites are listed in
the table at the bottom.
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Fig. 5. A splicing map of the leader region. The blue lines represent the known splice junctions. The thickness of the lines indicates the relative abundance of the sequence
reads which cover the splice junction. The numbers indicate the position of splice sites on theAd2 genome. The sequence reads covering these splice sites are listed in the
table at the bottom.
Table 3
The most signiﬁcant splice junctions in the MLTU.
Region Splice junction ORF Sequence reads from paired-end seq mRNA
Start End Begin Stop length Mock Ad-6 hpi Ad-12 hpi Ad-24 hpi Ad-36 hpi
Leader 6080 7100 352 223 187 166,717 573,713 Between leaders 1 and 2
Leader 7173 7941 64 29 40 32,416 45,039 Between leaders 2 and i
Leader 7173 9633 486 425 343 281,568 142,6350 Between leaders 2 and 3
Leader 8382 9633 24 15 28 32,309 54,467 13.6K protein
9724 10433 10434 10583 150 0 0 0 727 1198 New
L1 9724 11039 11040 12287 1248 41 33 96 48,483 75,495 52, 55K
L1 9724 12307 12308 14065 1758 0 0 0 1332 4577 IIIa
L2 9724 14149 14151 15866 1716 12 18 3 3683 25,497 Capsid protein pIII
9724 14455 14541 15866 1326 0 0 0 453 2536 New
9724 15029 15043 15153 111 0 0 0 1329 2531 New
9724 15056 15064 15153 90 0 0 0 5435 1528 New
L2 9724 15518 15873 16469 597 0 0 0 340 1413 New
L2 9724 15653 15873 16469 597 0 0 0 674 4509 New pVII (instead of 15853)
L2 9724 15659 15873 16469 597 8 16 11 2824 22,056 New pVII (instead of 15853)
L2 9724 15723 15873 16469 597 5 9 2 3279 13,724 New pVII (instead of 15853)
L2 9724 16515 16539 17648 1110 32 32 18 16289 89,029 Core protein pV
9724 17367 17428 17763 336 0 0 0 463 1956 New
L2 9724 17673 17676 17918 243 6 12 5 3142 17,648 Core prot precursor pX
L3 9724 17999 18001 18753 753 7 10 11 3092 26,407 Capsid prot precursor pVI
L3 9724 18801 18838 21744 2907 13 14 11 5418 39,521 Hexon pII
L3 9724 21649 21778 22392 615 10 1 3 807 6104 Protease
L4 9724 24094 24108 26525 2418 31 24 12 27968 61,766 100K protein
L4 9724 26204 26239 26826 588 13 2 0 4957 14,558 New L4-33K (instead of 26237)
L4 9724 26237 26239 26826 588 5 2 3 1673 4627 L4-33K and encapsidation prot 22K
L4 9724 26753 26952 26993 42 5 2 2 1455 9498 New
L4 26552 26753 9 0 15 31,039 88,362 L4-33K protein, 2nd intron
L4 9724 27030 27215 27898 684 0 0 0 593 3728 pVIII instead of 27194
L5 9724 27847 1 1 27 573 7784 Leaders 3–X
L5 9724 28375 35 17 7 6978 74,604 Leaders 3–Y
L5 9724 30437 0 1 11 1111 3503 Leaders 3–Z
L5 9724 31029 0 0 6 1685 14,441 Leader 3–ﬁber
L5 27981 31029 0 1 0 187 1228 X–ﬁber
L5 28560 31029 16 15 11 5447 36,841 Y–ﬁber
L5 30583 31029 0 0 0 4738 3021 Z–ﬁber
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the progression of the infection. As shown in Table 4, most of our
results were in agreement with previous reports, including the
poly(A) sites for E1B, L2, L3 E2B, E4 and E3B mRNAs. There was
only one dominant poly(A) site for these mRNAs, i.e. more than
96% of the reads covered each respective site. However, several
new poly(A) sites were identiﬁed. For example, ﬁve new L5 poly
Fig. 6. PCR veriﬁcation of new splice sites for pVII. The locations of the primers are shown at the top. Total RNA was extracted from mock (M) and Ad2-infected IMR-90 cells
at 12, 24 and 36 hpi and transcribed into cDNA. PCR was performed by using F1- and R-primer (A) or F2- and R-primer (B). NTC stands for control without template. Puriﬁed
DNA from adenovirus was used as control (Ad2).
Fig. 7. A splice map of ﬁber RNA. The red bars represent ﬁber transcript. The blue and green lines indicate splice sites. The numbers indicate the position of splice sites on the
Ad2 genome. The thickness of the lines indicates the relative abundance of the sequence reads covering the splice junctions. The sequence reads covering these splice sites
are listed in the table.
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(A) addition sites were found in addition to the previously reported
site at 32798 (Le Moullec et al., 1983). About 40% of the L5 mRNAs had
a poly(A) site at 32798 and about 32% at 32795. Two new L1 poly
(A) sites at 14112 and 14117 were identiﬁed, but they represented only
7.5% and 12.5% of all L1 poly(A) sites at 24 and 36 hpi, respectively.
The poly(A) site at 14118 was the most abundant and accounted for
over 70% of all L1 poly(A) sites, whereas the previously reported site
at 14113 accounted for less than 14% (Le Moullec et al., 1983). Two
previously identiﬁed L4 poly(A) sites at position nts 28228 and 28223
could be conﬁrmed here, although the site at 28228, was shown to be
the most abundant site for L3 (Le Moullec et al., 1983; Prescott and
Falck-Pedersen, 1994). Among four E3A poly(A) sites detected here,
twowere consistent with earlier studies (Ahmed et al., 1982) and they
were the most signiﬁcant sites. A novel E2A poly(A) site at 22416 was
identiﬁed but poly(A) addition at 22420 was slightly higher than
at 22416.
Conclusion
Adenovirus splice and polyadenylation sites were quantita-
tively mapped by using deep cDNA sequencing. As a result of
our ﬁndings the functional map of the adenovirus genome needs
revision. Although all adenovirus splice junction could be mapped
with great precision, the full structure of all adenovirus mRNAs
could not be deﬁned. An attempt to assemble full length mRNA
sequences proved impossible with available bioinformatics tools
due to the extreme overlapping nature of adenovirus mRNAs. It is
clear from the present results that adenovirus splicing is an
inaccurate process since more than 500 different splice sites could
be identiﬁed using sequence coverage of 100 as a criterion.
Although a few of the novel splices are likely to generate hitherto
undetected functional mRNAs it seems highly improbable that all
these sites are functional. This is most apparent in the region
which includes the exons of the tripartite leader. Here the strong
splice donor and acceptor sites are used in combinations with
numerous weaker partners. Polyadenylation, in contrast, appears
very precise and at some sites the poly(A) tail was added at the
same position in 97% of the cases or more. In a number of cases
our results are inconsistent with previously reported ﬁndings.
Although this is likely to be due to our use of a superior method, it
cannot be excluded that the differences are related to the use of
other host cells and virus strains.
Materials and methods
Cell culture and adenovirus infection
Human primary lung ﬁbroblast cells (IMR-90) purchased from
American Type Culture Collection (ATCC) were cultured in Eagle's
minimum essential medium (ATCC) supplemented with 10% fetal
bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. After
reaching conﬂuence, the cells were cultured for two more days in
order to synchronize them. Over 95% of the cells were in the G0/G1
phase as indicated by FACS analysis (Zhao et al., 2007). Synchronized
cells were mock-infected or infected with Ad2 at a multiplicity of 100
ﬂuorescence-forming units (FFU) per cell in serum-free medium
(Philipson, 1961). After 1 h adsorption at 37 1C, the medium was
replaced with complete EMEM containing 10% FBS and incubated at
37 1C. Infected cells were collected at 6, 12, 24, and 36 hours post
infection (hpi). Mock-infected cells were collected at 6 hpi.
RNA extraction, cDNA library preparation, and sequencing
Total RNA from adenovirus or mock-infected IMR-90 cells was
extracted using TRIZOL Reagent (Invitrogen). The quality of the
input RNA was controlled by the Bioanalyzer (Agilent Technolo-
gies). RNA was treated with RiboZero (Epicentre) to remove
ribosomal RNA and the libraries were constructed using the
ScriptSeq™ v2 RNA-Seq library preparation kit according to the
manufacturer's protocol (Epicentre). The cDNA libraries were
sequenced on the Genome Analyzer II or the Illumina HiSeq 2000.
Computational analysis of sequencing data
To evaluate the sequencing data and split virus and host cellular
reads, the reads of each sample were aligned to adenovirus type 2
(http://www.ncbi.nlm.nih.gov/nuccore/NC_001405) and human (hg19,
http://hgdownload.soe.ucsc.edu/goldenPath/hg19/bigZips/
chromFa.tar.gz) genome using SOAP2 (Li et al., 2009) with max-
imum of two mismatches. Then, the TopHat software (Trapnell et
al., 2009) was used to detect and predict splice junctions in the
Ad2 genome sequence also with less than 2 mismatches. Further-
more, the start and end positions of the intron should be in perfect
match with those of known introns. Finally, splice junctions,
detected in only one analysis, were considered as less reliable
and removed from list.
Table 4
Poly(A) addition sites and the efﬁciency of their usage.
mRNA Previous identiﬁed poly-A
addition site
Detected by
sequencing
Percentage
12 hpi
(%)
24 hpi
(%)
36 hpi
(%)
E1A 1626 –a 22.9b –
1628 – 18.6 –
1630 1630 – 58.6 100
E1B 4061 4061 – 96.8 97
L1 14113 (The most
abundant site)
14113 – 13.7 13.7
14118 14118 – 73 69.7
– 14112 4.5 4.5
– 14117 – 3 8
L2 17969 17969 – 99.3 98.8
L3 22443 22443 – 99.1 94.9
22437 – 0.9 3
L4 28228 28228 – 97.5 97.2
28223 (The most
abundant site)
28223 – 2.2 2.5
L5 32794 – 4.8 4.4
32795 – 32.8 34.4
32796 – 7.4 7.1
32797 – 6.9 6.4
32798 32798 – 44.1 40
32803 – 4.1 7.2
E3A 29792/29799/29801/
29804
29788 – 8.8 –
29791 – 10.2 –
29792 65.5 59.1 66.4
29799 34.5 21.9 33.6
E3B 30846 30846 – 100 100
E2A 22420 22420 56 51.2 54.5
22416 44 47 45.5
E2B and
IVa2
4050 4049 – 100 100
E4 32799 2.8
32802 32802 96.8 100 100
a Not detected.
b Percentage of sequence reads covering this poly(A) site.
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Identiﬁcation of the poly(A) addition site was done by using the
ﬁrst FASTQ ﬁle generated from strand-speciﬁc sequencing. The
sequence reads that covered more than 18 adenosines (poly
(A) tail) in a row were selected. The poly(A) sequence was then
removed and the upstream sequences were mapped to the
adenovirus genome.
PCR validation of new pVII splice sites
Three new alternative 30 splice sites, 15653, 15659 and 15723
for pVII, were identiﬁed by deep sequencing. To conﬁrm this
result, a PCR experiment was performed. Three primers were
designed, two forward primers (GTCACAGTCGCAAGATCACG and
CCTCTCGAGAAAGGCGTCTA), and one reverse primer (CTGGGCGA-
TATAAGGATGGA). The ﬁrst forward primer covered the splice
junction. Reverse transcription was performed by using Super-
Script™ III Reverse Transcriptase (Invitrogen by life Technologies).
PCR was done by using DreamTaq DNA polymerse (Thermo
SCIENTIFIC) under the condition of 2 min of denaturing, then 40
cycles of 30 s at 95 1C, 30 s at 60 1C and 15 s at 72 1C and ﬁnally
10 min extension at 72 1C. The PCR products were analysis by
electrophoresis on a 2% agarose gel.
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